News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
GenMark Diagnostics Reports Second Quarter 2011 Results
August 5, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK) today reported financial results for the second quarter ended June 30, 2011.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Deals
Spero bets up to $1.1B for Innovent’s autoimmune antibody
July 14, 2026
·
2 min read
·
Tristan Manalac
Lung cancer
AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B
July 14, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
FDA proposes streamlined requirements for ‘hub-and-spoke’ manufacturing models
July 14, 2026
·
2 min read
·
Nick Paul Taylor
Layoff Tracker
EMD Serono may trim R&D workforce by up to 70
July 13, 2026
·
68 min read
·
BioSpace Editorial Staff
